Filing Details

Accession Number:
0001209191-17-057210
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-10-17 18:54:46
Reporting Period:
2017-10-13
Accepted Time:
2017-10-17 18:54:46
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1438133 Tandem Diabetes Care Inc TNDM () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1238913 D Kim Blickenstaff C/O Tandem Diabetes Care, Inc.,
11045 Roselle Street
San Diego CA 92121
President & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-10-13 285,700 $3.50 486,494 No 4 P Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See footnote
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A Warrants to Purchase Common Stock Acquisiton 2017-10-13 285,700 $0.00 285,700 $3.50
Common Stock Series B Warrants to Purchase Common Stock Acquisiton 2017-10-13 285,700 $0.00 285,700 $3.50
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
285,700 2017-10-17 2022-10-17 No 4 P Indirect
285,700 2017-10-17 2018-04-17 No 4 P Indirect
Footnotes
  1. The reporting person has committed to purchase shares in connection with the Company's underwritten registered public offering of common stock.
  2. The amount of securities beneficially owned following the reported transactions reflects the 10 for 1 reverse stock split of the Issuer's issued and outstanding common stock which was effective on October 9, 2017.
  3. The securities are held by the Kim Blickenstaff Revocable Trust dated April 15, 2010